Skip to content
JoelGalvan

JoelGalvan

View Video Stories
  • Home
  • Business
  • Culture
  • Sports
  • Home
  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.
  • Home
  • Barclays

Tag: Barclays

Barclays Trims Keurig Dr Pepper (KDP) Price Target, Maintains Overweight Rating
Posted in Business

Barclays Trims Keurig Dr Pepper (KDP) Price Target, Maintains Overweight Rating

Estimated read time 2 min read
Posted on July 17, 2025
by Joelgalvan

Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the Best Non-Mega Cap NASDAQ Stocks to Buy Right Now. Barclays has…

Learn More Leave a Comment on Barclays Trims Keurig Dr Pepper (KDP) Price Target, Maintains Overweight Rating
Barclays Upgrades Ionis Pharmaceuticals (IONS) Stock, Raises PT
Posted in Business

Barclays Upgrades Ionis Pharmaceuticals (IONS) Stock, Raises PT

Estimated read time 2 min read
Posted on July 11, 2025
by Joelgalvan

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. Barclays upgraded…

Learn More Leave a Comment on Barclays Upgrades Ionis Pharmaceuticals (IONS) Stock, Raises PT
Barclays reshuffles APAC investment banking leadership to boost regional presence
Posted in Business

Barclays reshuffles APAC investment banking leadership to boost regional presence

Estimated read time 2 min read
Posted on July 3, 2025
by Joelgalvan

Barclays announced on Thursday a series of executive appointments within its Asia Pacific investment banking division, aiming to drive regional…

Learn More Leave a Comment on Barclays reshuffles APAC investment banking leadership to boost regional presence
Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
Posted in Business

Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June

Estimated read time 2 min read
Posted on June 25, 2025
by Joelgalvan

Barclays lowered its price target on Bausch & Lomb (NYSE: BLCO) from $19 to $16 on June 6, maintaining an…

Learn More Leave a Comment on Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
Barclays Initiates BioMarin Pharmaceutical Inc. (BMRN) with a Buy Rating
Posted in Business

Barclays Initiates BioMarin Pharmaceutical Inc. (BMRN) with a Buy Rating

Estimated read time 2 min read
Posted on June 24, 2025
by Joelgalvan

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)  is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. Gena Wang of…

Learn More Leave a Comment on Barclays Initiates BioMarin Pharmaceutical Inc. (BMRN) with a Buy Rating
Barclays Maintains Equal Weight Rating on Surgery Partners (SGRY), Cuts PT
Posted in Business

Barclays Maintains Equal Weight Rating on Surgery Partners (SGRY), Cuts PT

Estimated read time 2 min read
Posted on May 29, 2025
by Joelgalvan

On May 27, Barclays analyst Andrew Mok CFA maintained an Equal Weight rating on Surgery Partners, Inc. (NASDAQ:SGRY) and reduced…

Learn More Leave a Comment on Barclays Maintains Equal Weight Rating on Surgery Partners (SGRY), Cuts PT
Barclays Maintains Overweight Rating on Iron Mountain (IRM), Lifts PT
Posted in Business

Barclays Maintains Overweight Rating on Iron Mountain (IRM), Lifts PT

Estimated read time 2 min read
Posted on May 29, 2025
by Joelgalvan

On May 27, Barclays raised its price target on Iron Mountain Incorporated (NYSE:IRM) to $121 from $118 and maintained an…

Learn More Leave a Comment on Barclays Maintains Overweight Rating on Iron Mountain (IRM), Lifts PT
Barclays Keeps Equal Weight Rating on Equinix (EQIX), Raises PT
Posted in Business

Barclays Keeps Equal Weight Rating on Equinix (EQIX), Raises PT

Estimated read time 2 min read
Posted on May 27, 2025
by Joelgalvan

On May 27, Barclays raised the firm’s price target on Equinix, Inc. (NASDAQ:EQIX) to $837 from $834 and kept an…

Learn More Leave a Comment on Barclays Keeps Equal Weight Rating on Equinix (EQIX), Raises PT
Barclays strikes partnerships with UK music venues The O2 and Co-op Live
Posted in Business

Barclays strikes partnerships with UK music venues The O2 and Co-op Live

Estimated read time 3 min read
Posted on May 23, 2025
by Joelgalvan

Barclays, a consumer, corporate and investment bank, has struck up new partnerships with two prominent UK music venues, becoming Founding…

Learn More Leave a Comment on Barclays strikes partnerships with UK music venues The O2 and Co-op Live
Barclays Reiterates Buy Rating on Adobe (ADBE)
Posted in Business

Barclays Reiterates Buy Rating on Adobe (ADBE)

Estimated read time 2 min read
Posted on May 23, 2025
by Joelgalvan

On May 16, Barclays analyst Saket Kalia reiterated a Buy rating on Adobe Inc. (NASDAQ:ADBE) with a $567 price target…

Learn More Leave a Comment on Barclays Reiterates Buy Rating on Adobe (ADBE)

Posts navigation

← Older Articles

Recent Posts

  • Canada hockey players acquitted in sexual assault case
  • Asian stocks: Asian stocks snap six days of gains, bonds steady
  • Brandon Nakashima vs Cameron Norrie preview, head-to-head, prediction, odds, and pick 
  • England vs India: Zak Crawley books Ashes spot with excellent Old Trafford innings – and reacts to Lord’s needle | Cricket News
  • Schmidt urges Wallabies to rediscover ‘edge’ to send Lions series to decider

Recent Comments

No comments to show.

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.